Rebamipide Liquid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rebamipide Liquid, covering 2021-04-06 to 2021-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer [Phase 2]